Circulation, Vol 81, 1887-1898, Copyright © 1990 by American Heart Association
M Yokota, T Miyahara, M Iwase, M Watanabe, T Matsunami, S Kamihara, M Koide, H Saito and J Takeuchi
To investigate the mechanism of antianginal action of the calcium channel
blocker nisoldipine and to determine the reproducibility of the clinical
and hemodynamic events induced by supine leg exercise, 30 patients with
stable effort angina pectoris were studied. They were divided into two
groups; one group of 19 patients received a single 10- mg dose of
nisoldipine orally, and the other group of 11 patients received a single
dose of placebo orally. Chest pain was induced in all of 30 patients during
the control exercise test. After nisoldipine administration, chest pain was
not induced in 13 of 19 patients and was of lessened severity in five
patients with the same work load as those performing control exercise. ST
segment at peak exercise showed less severe depression after nisoldipine.
Systemic vascular resistance was reduced by 38% (p less than 0.001) at rest
and 22% (p less than 0.001) at peak exercise, and coronary vascular
resistance was reduced by 31% (p less than 0.01) at rest and 18% (p less
than 0.01) at peak exercise. Pulmonary artery wedge pressure fell from 6
+/- 1 to 3 +/- 1 mm Hg (p less than 0.001) at rest and from 28 +/- 3 to 11
+/- 2 mm Hg (p less than 0.001) at peak exercise. Coronary sinus flow at
rest and myocardial oxygen uptake both at rest and during exercise was not
modified by nisoldipine. However, coronary sinus flow at peak exercise
increased significantly from 219 +/- 24 to 249 +/- 31 ml/min (p less than
0.01) after nisoldipine, and myocardial oxygen uptake was not significantly
changed despite decreased coronary vascular resistance. The clinical and
hemodynamic events induced by the exercise during invasive studies (except
pulmonary artery wedge pressure at rest) were reproducible after placebo
administration. Our data demonstrate that increased coronary blood flow
could be the major mechanism of the antianginal action of nisoldipine in
supine leg exercise-induced angina.
ARTICLES
Hemodynamic mechanisms of antianginal action of calcium channel blocker nisoldipine in dynamic exercise-induced angina
Department of Clinical Laboratory, Nagoya University Hospital, Japan.
This article has been cited by other articles:
![]() |
M. Inagaki, M. Yokota, H. Izawa, R. Ishiki, K. Nagata, M. Iwase, Y. Yamada, M. Koide, and T. Sobue Impaired Force-Frequency Relations in Patients With Hypertensive Left Ventricular Hypertrophy : A Possible Physiological Marker of the Transition From Physiological to Pathological Hypertrophy Circulation, April 13, 1999; 99(14): 1822 - 1830. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Izawa, M. Yokota, Y. Takeichi, M. Inagaki, K. Nagata, M. Iwase, and T. Sobue Adrenergic Control of the Force-Frequency and Relaxation-Frequency Relations in Patients With Hypertrophic Cardiomyopathy Circulation, November 4, 1997; 96(9): 2959 - 2968. [Abstract] [Full Text] |
||||
![]() |
P. B.M. Clarkson, N. M. Wheeldon, R. J. MacFadyen, S. D. Pringle, and T. M. MacDonald Effects of Brain Natriuretic Peptide on Exercise Hemodynamics and Neurohormones in Isolated Diastolic Heart Failure Circulation, June 1, 1996; 93(11): 2037 - 2042. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1990 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |